{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:08:39Z","timestamp":1769123319554,"version":"3.49.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/501100006484","name":"Relypsa, Inc., a Vifor Pharma Group Company","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2018,5,4]]},"DOI":"10.1080\/14740338.2018.1462335","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T11:40:40Z","timestamp":1524051640000},"page":"525-535","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia"],"prefix":"10.1080","volume":"17","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[{"name":"Internal Medicine, Department of Medicine, Cardiovascular Center, University of Michigan School of Medicine, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahlia","family":"Garza","sequence":"additional","affiliation":[{"name":"Medical affairs, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,4,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.132"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1190333"},{"key":"CIT0003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease; 2004 [2017 Dec 18]. Available from: http:\/\/www2.kidney.org\/professionals\/KDOQI\/guidelines_bp\/"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019"},{"issue":"2","key":"CIT0005","first-page":"104","volume":"38","author":"Krogager ML","year":"2017","journal-title":"Eur Heart J"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx460"},{"issue":"2","key":"CIT0007","first-page":"113","volume":"38","author":"Pitt B","year":"2017","journal-title":"Eur Heart J"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx537"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1159\/000479802"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07821109"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2174\/157488711795177912"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-S013"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.01.416"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592"},{"issue":"13","key":"CIT0016","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy CW","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx026"},{"issue":"11","key":"CIT0018","first-page":"S212","volume":"21","author":"Epstein M","year":"2015","journal-title":"Am J Manag Care"},{"key":"CIT0019","volume-title":"Veltassa (patiromer) for oral suspension [package insert]","year":"2016"},{"key":"CIT0020","volume-title":"Veltassa (patiromer) summary of product characteristics","year":"2017"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1177\/1074248416629549"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7446"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410853"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1159\/000481270"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.270"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.11.011"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq502"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01170216"},{"issue":"4","key":"CIT0029","first-page":"S1","volume":"42","author":"National Kidney F","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2704"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2011.00849.x"},{"key":"CIT0032","first-page":"54","volume":"28","author":"Bushinsky D","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1159\/000451067"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx132.TO028"},{"key":"CIT0035","first-page":"301","volume":"28","author":"Rowan CG","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"CIT0036","first-page":"303","volume":"28","author":"Chatoth DK","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.402"},{"issue":"1","key":"CIT0038","first-page":"S503","volume":"59","author":"Rossignol P","year":"2016","journal-title":"Diabetologia"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1177\/1074248417691135"},{"issue":"5","key":"CIT0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/14740338.2016.1163335","volume":"15","author":"Pitt B","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012818"},{"key":"CIT0042","unstructured":"PL detail-document #300610, monitoring ACEIs and ARBs. Pharmacist\u2019s Letter\/Prescriber\u2019s Letter; 2014 [cited 2017 Feb 1]. Available from: http:\/\/prescribersletter.therapeuticresearch.com\/pl\/ArticlePDF.aspx?cs=&s=PRL&DocumentFileID=0&DetailID=300618&SegmentID=0"},{"key":"CIT0043","volume-title":"Kayexalate (sodium polystyrene sulfonate) [package insert]","year":"2009"},{"key":"CIT0044","volume-title":"Lokelma (sodium zirconium cyclosilicate) summary of product characteristics","year":"2018"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114686"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S129555"},{"key":"CIT0047","unstructured":"Agarwal R, Mayo M, Garza D, et al. A randomized, double-blind, placebo-controlled, parallel group study of patiromer for the enablement of spironolactone use for blood pressure control in patients with resistant hypertension and chronic kidney disease (AMBER): study design 14th Global Cardiovascular Clinical Trials Forum; 2017 [cited 2017 Jan 12]. Available from: https:\/\/static1.squarespace.com\/static\/58e21aa8b3db2bb290447da3\/t\/5a213f5f8165f51b7dc7acd9\/1512128351671\/Abstract_Agarwal.pdf"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.04.019"}],"updated-by":[{"DOI":"10.1080\/14740338.2018.1474044","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000}}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2018.1462335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:21:56Z","timestamp":1597450916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2018.1462335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,22]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5,4]]}},"alternative-id":["10.1080\/14740338.2018.1462335"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2018.1462335","relation":{"correction":[{"id-type":"doi","id":"10.1080\/14740338.2018.1474044","asserted-by":"object"}]},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}